Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Früh

Showing results (521-530 of 552) with videos related to

Pageof 56
Sort By:
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|March 5, 2005
A serpentinite-hosted ecosystem: the Lost City hydrothermal fieldDeborah S Kelley, Jeffrey A Karson, Gretchen L Früh-Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European expertsP M Putora, G F Fischer, M Früh, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Heart (British Cardiac Society)|September 16, 2011
Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre surveyIrene E van Geldorp, Tammo Delhaas, Roman A Gebauer, et al.
Gut|October 3, 2023
<i>HLA-DPA1*02:01~B1*01:01</i> is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cellsBritta F Zecher, David Ellinghaus, Sebastian Schloer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2021
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trialR A Soo, J-Y Han, U Dafni, et al.
Neurosurgical Focus|April 2, 2023
Successful weaning versus permanent cerebrospinal fluid diversion after aneurysmal subarachnoid hemorrhage: post hoc analysis of a Swiss multicenter studyAhmed El-Garci, Olivia Zindel-Geisseler, Noemi Dannecker, et al.
Nature Communications|January 30, 2025
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Pageof 56

Showing results (521-530 of 552) with videos related to

Sort By:
Pageof 56
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Science (New York, N.Y.)|March 5, 2005
A serpentinite-hosted ecosystem: the Lost City hydrothermal fieldDeborah S Kelley, Jeffrey A Karson, Gretchen L Früh-Green, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 24, 2020
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European expertsP M Putora, G F Fischer, M Früh, et al.
Oncoimmunology|December 3, 2021
Keratinocyte differentiation antigen-specific T cells in immune checkpoint inhibitor-treated NSCLC patients are associated with improved survivalFiamma Berner, Rebekka Niederer, Jolien J Luimstra, et al.
Heart (British Cardiac Society)|September 16, 2011
Impact of the permanent ventricular pacing site on left ventricular function in children: a retrospective multicentre surveyIrene E van Geldorp, Tammo Delhaas, Roman A Gebauer, et al.
Gut|October 3, 2023
<i>HLA-DPA1*02:01~B1*01:01</i> is a risk haplotype for primary sclerosing cholangitis mediating activation of NKp44+ NK cellsBritta F Zecher, David Ellinghaus, Sebastian Schloer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2021
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trialR A Soo, J-Y Han, U Dafni, et al.
Neurosurgical Focus|April 2, 2023
Successful weaning versus permanent cerebrospinal fluid diversion after aneurysmal subarachnoid hemorrhage: post hoc analysis of a Swiss multicenter studyAhmed El-Garci, Olivia Zindel-Geisseler, Noemi Dannecker, et al.
Nature Communications|January 30, 2025
Rhesus Cytomegalovirus-encoded Fcγ-binding glycoproteins facilitate viral evasion from IgG-mediated humoral immunityClaire E Otero, Sophia Petkova, Martin Ebermann, et al.
Science Immunology|June 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8<sup>+</sup> T cell priming and vaccine efficacy by the RhCMV/SIV vaccineScott G Hansen, Meaghan H Hancock, Daniel Malouli, et al.
Pageof 56